The phospholipase iPLA 2 γ is a major mediator releasing oxidized aliphatic chains from cardiolipin, integrating mitochondrial bioenergetics and signaling.
Autor: | Liu GY; From the Department of Chemistry, Washington University, Saint Louis, Missouri 63130 and., Moon SH; Division of Bioorganic Chemistry and Molecular Pharmacology, Department of Medicine., Jenkins CM; Division of Bioorganic Chemistry and Molecular Pharmacology, Department of Medicine., Li M; Division of Bioorganic Chemistry and Molecular Pharmacology, Department of Medicine., Sims HF; Division of Bioorganic Chemistry and Molecular Pharmacology, Department of Medicine., Guan S; Division of Bioorganic Chemistry and Molecular Pharmacology, Department of Medicine., Gross RW; From the Department of Chemistry, Washington University, Saint Louis, Missouri 63130 and rgross@wustl.edu.; Division of Bioorganic Chemistry and Molecular Pharmacology, Department of Medicine.; Department of Developmental Biology, and.; Center for Cardiovascular Research, Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri 63110. |
---|---|
Jazyk: | angličtina |
Zdroj: | The Journal of biological chemistry [J Biol Chem] 2017 Jun 23; Vol. 292 (25), pp. 10672-10684. Date of Electronic Publication: 2017 Apr 25. |
DOI: | 10.1074/jbc.M117.783068 |
Abstrakt: | Cardiolipin (CL) is a dimeric phospholipid with critical roles in mitochondrial bioenergetics and signaling. Recently, inhibition of the release of oxidized fatty acyl chains from CL by the calcium-independent phospholipase A (© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.) |
Databáze: | MEDLINE |
Externí odkaz: |